Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 25.51%14.08B | 27.33%48.9B | 35.36%11.22B | 40.18%38.41B | 39.39%10.57B | 43.73%10.18B | 42.66%9.37B | 34.44%8.29B | 32.82%27.4B | 30.93%7.58B |
| Cost of revenue | 19.44%3.5B | 16.73%12.59B | 19.72%2.93B | 25.15%10.79B | 19.69%2.79B | 24.75%2.78B | 32.25%2.77B | 24.50%2.45B | 30.66%8.62B | 28.29%2.33B |
| Gross profit | 27.67%10.58B | 31.47%36.31B | 41.93%8.29B | 47.09%27.62B | 48.16%7.78B | 52.47%7.4B | 47.52%6.61B | 39.07%5.84B | 33.83%18.78B | 32.15%5.25B |
| Operating expense | 16.18%6.92B | 18.40%26.12B | 23.97%5.96B | 28.84%22.06B | 23.09%5.79B | 25.43%5.54B | 44.86%5.92B | 22.88%4.81B | 37.50%17.12B | 30.82%4.7B |
| Operating profit | 57.11%3.66B | 83.33%10.19B | 125.70%2.33B | 235.75%5.56B | 264.10%1.99B | 329.17%1.85B | 75.26%687M | 260.49%1.03B | 4.94%1.66B | 44.83%546M |
| Net non-operating interest income (expenses) | 2M | 300.00%4M | 0 | -2M | 0 | -1M | -1M | 0 | 0 | 0 |
| Non-operating interest income | --2M | --6M | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Non-operating interest expense | --0 | 0.00%2M | --0 | --2M | --0 | --1M | --1M | --0 | --0 | --0 |
| Net investment income | -61.29%12M | 250.00%7M | 29.17%31M | 300.00%12M | 0.00%6M | 10.00%11M | -60.00%2M | 2,300.00%24M | 3M | |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 1.49B | 0 | 0 | 10.64%-42M | 0 | |||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 10M | -114.29%-2M | 0 | -92.59%14M | -100.50%-1M | 68.75%-5M | -40.00%3M | 17M | 9,550.00%189M | 5,100.00%200M |
| Less:Restructuring and mergern&acquisition | --1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | ---11M | 0.00%2M | ---- | 100.98%2M | 100.50%1M | --5M | --3M | ---7M | -10,350.00%-205M | -5,100.00%-200M |
| Less:Write off | ---- | --0 | --0 | -200.00%-16M | --0 | --0 | ---6M | ---10M | --16M | --0 |
| Other non-operating income (expenses) | 80.00%9M | 200.00%3M | -54.55%5M | -80.00%1M | -33.33%2M | 1M | 1M | -8.33%11M | 25.00%5M | |
| Income before tax | 120.70%5.16B | 82.17%10.22B | 121.82%2.34B | 204.95%5.61B | 164.77%2B | 354.90%1.86B | 82.51%699M | 259.73%1.05B | 19.18%1.84B | 127.41%755M |
| Income tax | 507.87%1.62B | 55.56%2.21B | -23.50%267M | 151.68%1.42B | 80.00%288M | 287.50%589M | 37.06%196M | 217.27%349M | 21.51%565M | 321.05%160M |
| Net income | 70.79%3.54B | 91.23%8B | 193.76%2.07B | 228.49%4.19B | 187.56%1.71B | 394.53%1.27B | 108.71%503M | 287.36%705M | 18.18%1.27B | 102.38%595M |
| Net income continuous operations | 70.79%3.54B | 91.21%8B | 193.76%2.07B | 228.57%4.19B | 187.56%1.71B | 394.92%1.27B | 109.58%503M | 285.25%705M | 18.18%1.27B | 102.38%595M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 70.79%3.54B | 91.23%8B | 193.76%2.07B | 228.49%4.19B | 187.56%1.71B | 394.53%1.27B | 108.71%503M | 287.36%705M | 18.18%1.27B | 102.38%595M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 70.79%3.54B | 91.23%8B | 193.76%2.07B | 228.49%4.19B | 187.56%1.71B | 394.53%1.27B | 108.71%503M | 287.36%705M | 18.18%1.27B | 102.38%595M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 71.22%9.785 | 91.26%22.09 | 193.83%5.715 | 228.59%11.55 | 187.80%4.72 | 392.25%3.495 | 110.61%1.39 | 285.15%1.945 | 18.15%3.515 | 102.47%1.64 |
| Diluted earnings per share | 71.22%9.785 | 91.26%22.09 | 193.83%5.715 | 228.59%11.55 | 187.80%4.72 | 394.53%3.4931 | 110.28%1.3879 | 285.15%1.945 | 18.15%3.515 | 102.47%1.64 |
| Dividend per share | 0 | 91.49%2.25 | 0 | 20.51%1.175 | 20.51%1.175 | 0 | 0 | 0 | 2.63%0.975 | 2.63%0.975 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |